INS and pancreatic neuroendocrine tumor: The patient’s clinical manifestations, hypoglycemia, insulin/blood glucose > 0.4, pancreatic enhancement CT, and upper abdominal enhanced MRI results supported the diagnosis of an islet cell tumor.